Lung Cancer, Nonsmall Cell, Stage IIIA

DBCOND0150709NeoplasmsRespiratory Tract Diseases

Lung Cancer, Nonsmall Cell, Stage IIIA is the indication for 3 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as
Stage IIIA Non Small Cell Lung Cancer · Stage IIIA Non-Small Cell Lung Cancer · Non-small Cell Lung Cancer Stage IIIA · Non Small Cell Lung Cancer Stage IIIA · IIIA Stage Non-small Cell Lung Cancer
Classified under
Indicated drugs

Resolves to

Vocabularies
MedDRA10025053UMLSC0278983

What you can answer from here — as of October 03, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
86Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Lung Cancer, Nonsmall Cell, Stage IIIA share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In